The annual rate of decline in FEV1 is higher in patients with sporadic LAM, higher serum VEGF-D values, greater degree of dyspnea, greater extent of pulmonary cysts on CT, or a positive bronchodilator response.3 This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.